InterventionsHumans271,685 participantsCohort study

Cardiovascular outcomes with tirzepatide versus semaglutide in type 2 diabetes

Figure 1 from Journal of Diabetes and Metabolic Disorders
Open the figure at full size
Figure 1Al-Nusair et al.

Journal of Diabetes and Metabolic Disorders

The paper

Georgetown University · Children's National

Journal of Diabetes and Metabolic Disorders · 5 Oct 2026

doi.org/10.1007/s40200-026-02087-zPubMed 42840232

More on Type 2 diabetes